Medical Care
Global RNA Analysis Transcriptomics Market Research Report 2025
- Apr 07, 25
- ID: 167193
- Pages: 100
- Figures: 92
- Views: 68
The global market for RNA Analysis Transcriptomics was valued at US$ 708 million in the year 2024 and is projected to reach a revised size of US$ 1333 million by 2031, growing at a CAGR of 9.6% during the forecast period.
Transcriptomics is the analysis of the RNA transcripts produced by the genotype at a given time that provides a link between the genome, the proteome, and the cellular phenotype. It is a global approach, which together with genomics, proteomics, and metabolomics has evolved in recent years.
Transcriptomics is the analysis of the RNA transcripts produced by the genotype at a given time that provides a link between the genome, the proteome, and the cellular phenotype. It is a global approach, which together with genomics, proteomics, and metabolomics has evolved in recent years.
This report aims to provide a comprehensive presentation of the global market for RNA Analysis Transcriptomics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Analysis Transcriptomics.
The RNA Analysis Transcriptomics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global RNA Analysis Transcriptomics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNA Analysis Transcriptomics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Bio-Rad Laboratories
Merck KGaA
Agilent Technologies
Illumina
QIAGEN N.V.
F. Hoffmann-La Roche
Danaher Corporation
Fluidigm Corporation
Eurofins Scientific
Sequentia Biotech
Acobiom
GenXPro
CD Genomics
Promega Corporation
Lexogen
Cenix BioScience
Segment by Type
Microarrays
Sequencing
Polymerase Chain Reaction (PCR)
RNA Interference
Segment by Application
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Hospitals
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNA Analysis Transcriptomics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Transcriptomics is the analysis of the RNA transcripts produced by the genotype at a given time that provides a link between the genome, the proteome, and the cellular phenotype. It is a global approach, which together with genomics, proteomics, and metabolomics has evolved in recent years.
Transcriptomics is the analysis of the RNA transcripts produced by the genotype at a given time that provides a link between the genome, the proteome, and the cellular phenotype. It is a global approach, which together with genomics, proteomics, and metabolomics has evolved in recent years.
This report aims to provide a comprehensive presentation of the global market for RNA Analysis Transcriptomics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Analysis Transcriptomics.
The RNA Analysis Transcriptomics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global RNA Analysis Transcriptomics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNA Analysis Transcriptomics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Bio-Rad Laboratories
Merck KGaA
Agilent Technologies
Illumina
QIAGEN N.V.
F. Hoffmann-La Roche
Danaher Corporation
Fluidigm Corporation
Eurofins Scientific
Sequentia Biotech
Acobiom
GenXPro
CD Genomics
Promega Corporation
Lexogen
Cenix BioScience
Segment by Type
Microarrays
Sequencing
Polymerase Chain Reaction (PCR)
RNA Interference
Segment by Application
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Hospitals
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNA Analysis Transcriptomics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA Analysis Transcriptomics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Microarrays
1.2.3 Sequencing
1.2.4 Polymerase Chain Reaction (PCR)
1.2.5 RNA Interference
1.3 Market by Application
1.3.1 Global RNA Analysis Transcriptomics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Academic & Research Institutes
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Hospitals
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNA Analysis Transcriptomics Market Perspective (2020-2031)
2.2 Global RNA Analysis Transcriptomics Growth Trends by Region
2.2.1 Global RNA Analysis Transcriptomics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 RNA Analysis Transcriptomics Historic Market Size by Region (2020-2025)
2.2.3 RNA Analysis Transcriptomics Forecasted Market Size by Region (2026-2031)
2.3 RNA Analysis Transcriptomics Market Dynamics
2.3.1 RNA Analysis Transcriptomics Industry Trends
2.3.2 RNA Analysis Transcriptomics Market Drivers
2.3.3 RNA Analysis Transcriptomics Market Challenges
2.3.4 RNA Analysis Transcriptomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNA Analysis Transcriptomics Players by Revenue
3.1.1 Global Top RNA Analysis Transcriptomics Players by Revenue (2020-2025)
3.1.2 Global RNA Analysis Transcriptomics Revenue Market Share by Players (2020-2025)
3.2 Global RNA Analysis Transcriptomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by RNA Analysis Transcriptomics Revenue
3.4 Global RNA Analysis Transcriptomics Market Concentration Ratio
3.4.1 Global RNA Analysis Transcriptomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA Analysis Transcriptomics Revenue in 2024
3.5 Global Key Players of RNA Analysis Transcriptomics Head office and Area Served
3.6 Global Key Players of RNA Analysis Transcriptomics, Product and Application
3.7 Global Key Players of RNA Analysis Transcriptomics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA Analysis Transcriptomics Breakdown Data by Type
4.1 Global RNA Analysis Transcriptomics Historic Market Size by Type (2020-2025)
4.2 Global RNA Analysis Transcriptomics Forecasted Market Size by Type (2026-2031)
5 RNA Analysis Transcriptomics Breakdown Data by Application
5.1 Global RNA Analysis Transcriptomics Historic Market Size by Application (2020-2025)
5.2 Global RNA Analysis Transcriptomics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America RNA Analysis Transcriptomics Market Size (2020-2031)
6.2 North America RNA Analysis Transcriptomics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America RNA Analysis Transcriptomics Market Size by Country (2020-2025)
6.4 North America RNA Analysis Transcriptomics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNA Analysis Transcriptomics Market Size (2020-2031)
7.2 Europe RNA Analysis Transcriptomics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe RNA Analysis Transcriptomics Market Size by Country (2020-2025)
7.4 Europe RNA Analysis Transcriptomics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNA Analysis Transcriptomics Market Size (2020-2031)
8.2 Asia-Pacific RNA Analysis Transcriptomics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific RNA Analysis Transcriptomics Market Size by Region (2020-2025)
8.4 Asia-Pacific RNA Analysis Transcriptomics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNA Analysis Transcriptomics Market Size (2020-2031)
9.2 Latin America RNA Analysis Transcriptomics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America RNA Analysis Transcriptomics Market Size by Country (2020-2025)
9.4 Latin America RNA Analysis Transcriptomics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNA Analysis Transcriptomics Market Size (2020-2031)
10.2 Middle East & Africa RNA Analysis Transcriptomics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa RNA Analysis Transcriptomics Market Size by Country (2020-2025)
10.4 Middle East & Africa RNA Analysis Transcriptomics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific RNA Analysis Transcriptomics Introduction
11.1.4 Thermo Fisher Scientific Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Details
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories RNA Analysis Transcriptomics Introduction
11.2.4 Bio-Rad Laboratories Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Details
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA RNA Analysis Transcriptomics Introduction
11.3.4 Merck KGaA Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.3.5 Merck KGaA Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies RNA Analysis Transcriptomics Introduction
11.4.4 Agilent Technologies Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.4.5 Agilent Technologies Recent Development
11.5 Illumina
11.5.1 Illumina Company Details
11.5.2 Illumina Business Overview
11.5.3 Illumina RNA Analysis Transcriptomics Introduction
11.5.4 Illumina Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.5.5 Illumina Recent Development
11.6 QIAGEN N.V.
11.6.1 QIAGEN N.V. Company Details
11.6.2 QIAGEN N.V. Business Overview
11.6.3 QIAGEN N.V. RNA Analysis Transcriptomics Introduction
11.6.4 QIAGEN N.V. Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.6.5 QIAGEN N.V. Recent Development
11.7 F. Hoffmann-La Roche
11.7.1 F. Hoffmann-La Roche Company Details
11.7.2 F. Hoffmann-La Roche Business Overview
11.7.3 F. Hoffmann-La Roche RNA Analysis Transcriptomics Introduction
11.7.4 F. Hoffmann-La Roche Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.7.5 F. Hoffmann-La Roche Recent Development
11.8 Danaher Corporation
11.8.1 Danaher Corporation Company Details
11.8.2 Danaher Corporation Business Overview
11.8.3 Danaher Corporation RNA Analysis Transcriptomics Introduction
11.8.4 Danaher Corporation Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.8.5 Danaher Corporation Recent Development
11.9 Fluidigm Corporation
11.9.1 Fluidigm Corporation Company Details
11.9.2 Fluidigm Corporation Business Overview
11.9.3 Fluidigm Corporation RNA Analysis Transcriptomics Introduction
11.9.4 Fluidigm Corporation Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.9.5 Fluidigm Corporation Recent Development
11.10 Eurofins Scientific
11.10.1 Eurofins Scientific Company Details
11.10.2 Eurofins Scientific Business Overview
11.10.3 Eurofins Scientific RNA Analysis Transcriptomics Introduction
11.10.4 Eurofins Scientific Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.10.5 Eurofins Scientific Recent Development
11.11 Sequentia Biotech
11.11.1 Sequentia Biotech Company Details
11.11.2 Sequentia Biotech Business Overview
11.11.3 Sequentia Biotech RNA Analysis Transcriptomics Introduction
11.11.4 Sequentia Biotech Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.11.5 Sequentia Biotech Recent Development
11.12 Acobiom
11.12.1 Acobiom Company Details
11.12.2 Acobiom Business Overview
11.12.3 Acobiom RNA Analysis Transcriptomics Introduction
11.12.4 Acobiom Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.12.5 Acobiom Recent Development
11.13 GenXPro
11.13.1 GenXPro Company Details
11.13.2 GenXPro Business Overview
11.13.3 GenXPro RNA Analysis Transcriptomics Introduction
11.13.4 GenXPro Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.13.5 GenXPro Recent Development
11.14 CD Genomics
11.14.1 CD Genomics Company Details
11.14.2 CD Genomics Business Overview
11.14.3 CD Genomics RNA Analysis Transcriptomics Introduction
11.14.4 CD Genomics Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.14.5 CD Genomics Recent Development
11.15 Promega Corporation
11.15.1 Promega Corporation Company Details
11.15.2 Promega Corporation Business Overview
11.15.3 Promega Corporation RNA Analysis Transcriptomics Introduction
11.15.4 Promega Corporation Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.15.5 Promega Corporation Recent Development
11.16 Lexogen
11.16.1 Lexogen Company Details
11.16.2 Lexogen Business Overview
11.16.3 Lexogen RNA Analysis Transcriptomics Introduction
11.16.4 Lexogen Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.16.5 Lexogen Recent Development
11.17 Cenix BioScience
11.17.1 Cenix BioScience Company Details
11.17.2 Cenix BioScience Business Overview
11.17.3 Cenix BioScience RNA Analysis Transcriptomics Introduction
11.17.4 Cenix BioScience Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.17.5 Cenix BioScience Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA Analysis Transcriptomics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Microarrays
1.2.3 Sequencing
1.2.4 Polymerase Chain Reaction (PCR)
1.2.5 RNA Interference
1.3 Market by Application
1.3.1 Global RNA Analysis Transcriptomics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Academic & Research Institutes
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Hospitals
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNA Analysis Transcriptomics Market Perspective (2020-2031)
2.2 Global RNA Analysis Transcriptomics Growth Trends by Region
2.2.1 Global RNA Analysis Transcriptomics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 RNA Analysis Transcriptomics Historic Market Size by Region (2020-2025)
2.2.3 RNA Analysis Transcriptomics Forecasted Market Size by Region (2026-2031)
2.3 RNA Analysis Transcriptomics Market Dynamics
2.3.1 RNA Analysis Transcriptomics Industry Trends
2.3.2 RNA Analysis Transcriptomics Market Drivers
2.3.3 RNA Analysis Transcriptomics Market Challenges
2.3.4 RNA Analysis Transcriptomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNA Analysis Transcriptomics Players by Revenue
3.1.1 Global Top RNA Analysis Transcriptomics Players by Revenue (2020-2025)
3.1.2 Global RNA Analysis Transcriptomics Revenue Market Share by Players (2020-2025)
3.2 Global RNA Analysis Transcriptomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by RNA Analysis Transcriptomics Revenue
3.4 Global RNA Analysis Transcriptomics Market Concentration Ratio
3.4.1 Global RNA Analysis Transcriptomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA Analysis Transcriptomics Revenue in 2024
3.5 Global Key Players of RNA Analysis Transcriptomics Head office and Area Served
3.6 Global Key Players of RNA Analysis Transcriptomics, Product and Application
3.7 Global Key Players of RNA Analysis Transcriptomics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA Analysis Transcriptomics Breakdown Data by Type
4.1 Global RNA Analysis Transcriptomics Historic Market Size by Type (2020-2025)
4.2 Global RNA Analysis Transcriptomics Forecasted Market Size by Type (2026-2031)
5 RNA Analysis Transcriptomics Breakdown Data by Application
5.1 Global RNA Analysis Transcriptomics Historic Market Size by Application (2020-2025)
5.2 Global RNA Analysis Transcriptomics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America RNA Analysis Transcriptomics Market Size (2020-2031)
6.2 North America RNA Analysis Transcriptomics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America RNA Analysis Transcriptomics Market Size by Country (2020-2025)
6.4 North America RNA Analysis Transcriptomics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNA Analysis Transcriptomics Market Size (2020-2031)
7.2 Europe RNA Analysis Transcriptomics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe RNA Analysis Transcriptomics Market Size by Country (2020-2025)
7.4 Europe RNA Analysis Transcriptomics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNA Analysis Transcriptomics Market Size (2020-2031)
8.2 Asia-Pacific RNA Analysis Transcriptomics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific RNA Analysis Transcriptomics Market Size by Region (2020-2025)
8.4 Asia-Pacific RNA Analysis Transcriptomics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNA Analysis Transcriptomics Market Size (2020-2031)
9.2 Latin America RNA Analysis Transcriptomics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America RNA Analysis Transcriptomics Market Size by Country (2020-2025)
9.4 Latin America RNA Analysis Transcriptomics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNA Analysis Transcriptomics Market Size (2020-2031)
10.2 Middle East & Africa RNA Analysis Transcriptomics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa RNA Analysis Transcriptomics Market Size by Country (2020-2025)
10.4 Middle East & Africa RNA Analysis Transcriptomics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific RNA Analysis Transcriptomics Introduction
11.1.4 Thermo Fisher Scientific Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Details
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories RNA Analysis Transcriptomics Introduction
11.2.4 Bio-Rad Laboratories Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Details
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA RNA Analysis Transcriptomics Introduction
11.3.4 Merck KGaA Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.3.5 Merck KGaA Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies RNA Analysis Transcriptomics Introduction
11.4.4 Agilent Technologies Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.4.5 Agilent Technologies Recent Development
11.5 Illumina
11.5.1 Illumina Company Details
11.5.2 Illumina Business Overview
11.5.3 Illumina RNA Analysis Transcriptomics Introduction
11.5.4 Illumina Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.5.5 Illumina Recent Development
11.6 QIAGEN N.V.
11.6.1 QIAGEN N.V. Company Details
11.6.2 QIAGEN N.V. Business Overview
11.6.3 QIAGEN N.V. RNA Analysis Transcriptomics Introduction
11.6.4 QIAGEN N.V. Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.6.5 QIAGEN N.V. Recent Development
11.7 F. Hoffmann-La Roche
11.7.1 F. Hoffmann-La Roche Company Details
11.7.2 F. Hoffmann-La Roche Business Overview
11.7.3 F. Hoffmann-La Roche RNA Analysis Transcriptomics Introduction
11.7.4 F. Hoffmann-La Roche Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.7.5 F. Hoffmann-La Roche Recent Development
11.8 Danaher Corporation
11.8.1 Danaher Corporation Company Details
11.8.2 Danaher Corporation Business Overview
11.8.3 Danaher Corporation RNA Analysis Transcriptomics Introduction
11.8.4 Danaher Corporation Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.8.5 Danaher Corporation Recent Development
11.9 Fluidigm Corporation
11.9.1 Fluidigm Corporation Company Details
11.9.2 Fluidigm Corporation Business Overview
11.9.3 Fluidigm Corporation RNA Analysis Transcriptomics Introduction
11.9.4 Fluidigm Corporation Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.9.5 Fluidigm Corporation Recent Development
11.10 Eurofins Scientific
11.10.1 Eurofins Scientific Company Details
11.10.2 Eurofins Scientific Business Overview
11.10.3 Eurofins Scientific RNA Analysis Transcriptomics Introduction
11.10.4 Eurofins Scientific Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.10.5 Eurofins Scientific Recent Development
11.11 Sequentia Biotech
11.11.1 Sequentia Biotech Company Details
11.11.2 Sequentia Biotech Business Overview
11.11.3 Sequentia Biotech RNA Analysis Transcriptomics Introduction
11.11.4 Sequentia Biotech Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.11.5 Sequentia Biotech Recent Development
11.12 Acobiom
11.12.1 Acobiom Company Details
11.12.2 Acobiom Business Overview
11.12.3 Acobiom RNA Analysis Transcriptomics Introduction
11.12.4 Acobiom Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.12.5 Acobiom Recent Development
11.13 GenXPro
11.13.1 GenXPro Company Details
11.13.2 GenXPro Business Overview
11.13.3 GenXPro RNA Analysis Transcriptomics Introduction
11.13.4 GenXPro Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.13.5 GenXPro Recent Development
11.14 CD Genomics
11.14.1 CD Genomics Company Details
11.14.2 CD Genomics Business Overview
11.14.3 CD Genomics RNA Analysis Transcriptomics Introduction
11.14.4 CD Genomics Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.14.5 CD Genomics Recent Development
11.15 Promega Corporation
11.15.1 Promega Corporation Company Details
11.15.2 Promega Corporation Business Overview
11.15.3 Promega Corporation RNA Analysis Transcriptomics Introduction
11.15.4 Promega Corporation Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.15.5 Promega Corporation Recent Development
11.16 Lexogen
11.16.1 Lexogen Company Details
11.16.2 Lexogen Business Overview
11.16.3 Lexogen RNA Analysis Transcriptomics Introduction
11.16.4 Lexogen Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.16.5 Lexogen Recent Development
11.17 Cenix BioScience
11.17.1 Cenix BioScience Company Details
11.17.2 Cenix BioScience Business Overview
11.17.3 Cenix BioScience RNA Analysis Transcriptomics Introduction
11.17.4 Cenix BioScience Revenue in RNA Analysis Transcriptomics Business (2020-2025)
11.17.5 Cenix BioScience Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global RNA Analysis Transcriptomics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Microarrays
Table 3. Key Players of Sequencing
Table 4. Key Players of Polymerase Chain Reaction (PCR)
Table 5. Key Players of RNA Interference
Table 6. Global RNA Analysis Transcriptomics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global RNA Analysis Transcriptomics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global RNA Analysis Transcriptomics Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global RNA Analysis Transcriptomics Market Share by Region (2020-2025)
Table 10. Global RNA Analysis Transcriptomics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global RNA Analysis Transcriptomics Market Share by Region (2026-2031)
Table 12. RNA Analysis Transcriptomics Market Trends
Table 13. RNA Analysis Transcriptomics Market Drivers
Table 14. RNA Analysis Transcriptomics Market Challenges
Table 15. RNA Analysis Transcriptomics Market Restraints
Table 16. Global RNA Analysis Transcriptomics Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global RNA Analysis Transcriptomics Market Share by Players (2020-2025)
Table 18. Global Top RNA Analysis Transcriptomics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Analysis Transcriptomics as of 2024)
Table 19. Ranking of Global Top RNA Analysis Transcriptomics Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by RNA Analysis Transcriptomics Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of RNA Analysis Transcriptomics, Headquarters and Area Served
Table 22. Global Key Players of RNA Analysis Transcriptomics, Product and Application
Table 23. Global Key Players of RNA Analysis Transcriptomics, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global RNA Analysis Transcriptomics Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global RNA Analysis Transcriptomics Revenue Market Share by Type (2020-2025)
Table 27. Global RNA Analysis Transcriptomics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global RNA Analysis Transcriptomics Revenue Market Share by Type (2026-2031)
Table 29. Global RNA Analysis Transcriptomics Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global RNA Analysis Transcriptomics Revenue Market Share by Application (2020-2025)
Table 31. Global RNA Analysis Transcriptomics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global RNA Analysis Transcriptomics Revenue Market Share by Application (2026-2031)
Table 33. North America RNA Analysis Transcriptomics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America RNA Analysis Transcriptomics Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America RNA Analysis Transcriptomics Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe RNA Analysis Transcriptomics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe RNA Analysis Transcriptomics Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe RNA Analysis Transcriptomics Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific RNA Analysis Transcriptomics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific RNA Analysis Transcriptomics Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific RNA Analysis Transcriptomics Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America RNA Analysis Transcriptomics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America RNA Analysis Transcriptomics Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America RNA Analysis Transcriptomics Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa RNA Analysis Transcriptomics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa RNA Analysis Transcriptomics Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa RNA Analysis Transcriptomics Market Size by Country (2026-2031) & (US$ Million)
Table 48. Thermo Fisher Scientific Company Details
Table 49. Thermo Fisher Scientific Business Overview
Table 50. Thermo Fisher Scientific RNA Analysis Transcriptomics Product
Table 51. Thermo Fisher Scientific Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 52. Thermo Fisher Scientific Recent Development
Table 53. Bio-Rad Laboratories Company Details
Table 54. Bio-Rad Laboratories Business Overview
Table 55. Bio-Rad Laboratories RNA Analysis Transcriptomics Product
Table 56. Bio-Rad Laboratories Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 57. Bio-Rad Laboratories Recent Development
Table 58. Merck KGaA Company Details
Table 59. Merck KGaA Business Overview
Table 60. Merck KGaA RNA Analysis Transcriptomics Product
Table 61. Merck KGaA Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 62. Merck KGaA Recent Development
Table 63. Agilent Technologies Company Details
Table 64. Agilent Technologies Business Overview
Table 65. Agilent Technologies RNA Analysis Transcriptomics Product
Table 66. Agilent Technologies Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 67. Agilent Technologies Recent Development
Table 68. Illumina Company Details
Table 69. Illumina Business Overview
Table 70. Illumina RNA Analysis Transcriptomics Product
Table 71. Illumina Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 72. Illumina Recent Development
Table 73. QIAGEN N.V. Company Details
Table 74. QIAGEN N.V. Business Overview
Table 75. QIAGEN N.V. RNA Analysis Transcriptomics Product
Table 76. QIAGEN N.V. Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 77. QIAGEN N.V. Recent Development
Table 78. F. Hoffmann-La Roche Company Details
Table 79. F. Hoffmann-La Roche Business Overview
Table 80. F. Hoffmann-La Roche RNA Analysis Transcriptomics Product
Table 81. F. Hoffmann-La Roche Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 82. F. Hoffmann-La Roche Recent Development
Table 83. Danaher Corporation Company Details
Table 84. Danaher Corporation Business Overview
Table 85. Danaher Corporation RNA Analysis Transcriptomics Product
Table 86. Danaher Corporation Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 87. Danaher Corporation Recent Development
Table 88. Fluidigm Corporation Company Details
Table 89. Fluidigm Corporation Business Overview
Table 90. Fluidigm Corporation RNA Analysis Transcriptomics Product
Table 91. Fluidigm Corporation Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 92. Fluidigm Corporation Recent Development
Table 93. Eurofins Scientific Company Details
Table 94. Eurofins Scientific Business Overview
Table 95. Eurofins Scientific RNA Analysis Transcriptomics Product
Table 96. Eurofins Scientific Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 97. Eurofins Scientific Recent Development
Table 98. Sequentia Biotech Company Details
Table 99. Sequentia Biotech Business Overview
Table 100. Sequentia Biotech RNA Analysis Transcriptomics Product
Table 101. Sequentia Biotech Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 102. Sequentia Biotech Recent Development
Table 103. Acobiom Company Details
Table 104. Acobiom Business Overview
Table 105. Acobiom RNA Analysis Transcriptomics Product
Table 106. Acobiom Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 107. Acobiom Recent Development
Table 108. GenXPro Company Details
Table 109. GenXPro Business Overview
Table 110. GenXPro RNA Analysis Transcriptomics Product
Table 111. GenXPro Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 112. GenXPro Recent Development
Table 113. CD Genomics Company Details
Table 114. CD Genomics Business Overview
Table 115. CD Genomics RNA Analysis Transcriptomics Product
Table 116. CD Genomics Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 117. CD Genomics Recent Development
Table 118. Promega Corporation Company Details
Table 119. Promega Corporation Business Overview
Table 120. Promega Corporation RNA Analysis Transcriptomics Product
Table 121. Promega Corporation Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 122. Promega Corporation Recent Development
Table 123. Lexogen Company Details
Table 124. Lexogen Business Overview
Table 125. Lexogen RNA Analysis Transcriptomics Product
Table 126. Lexogen Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 127. Lexogen Recent Development
Table 128. Cenix BioScience Company Details
Table 129. Cenix BioScience Business Overview
Table 130. Cenix BioScience RNA Analysis Transcriptomics Product
Table 131. Cenix BioScience Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 132. Cenix BioScience Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. RNA Analysis Transcriptomics Picture
Figure 2. Global RNA Analysis Transcriptomics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global RNA Analysis Transcriptomics Market Share by Type: 2024 VS 2031
Figure 4. Microarrays Features
Figure 5. Sequencing Features
Figure 6. Polymerase Chain Reaction (PCR) Features
Figure 7. RNA Interference Features
Figure 8. Global RNA Analysis Transcriptomics Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global RNA Analysis Transcriptomics Market Share by Application: 2024 VS 2031
Figure 10. Academic & Research Institutes Case Studies
Figure 11. Pharmaceutical & Biotechnology Companies Case Studies
Figure 12. Hospitals Case Studies
Figure 13. RNA Analysis Transcriptomics Report Years Considered
Figure 14. Global RNA Analysis Transcriptomics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global RNA Analysis Transcriptomics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global RNA Analysis Transcriptomics Market Share by Region: 2024 VS 2031
Figure 17. Global RNA Analysis Transcriptomics Market Share by Players in 2024
Figure 18. Global Top RNA Analysis Transcriptomics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Analysis Transcriptomics as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by RNA Analysis Transcriptomics Revenue in 2024
Figure 20. North America RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America RNA Analysis Transcriptomics Market Share by Country (2020-2031)
Figure 22. United States RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe RNA Analysis Transcriptomics Market Share by Country (2020-2031)
Figure 26. Germany RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific RNA Analysis Transcriptomics Market Share by Region (2020-2031)
Figure 34. China RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America RNA Analysis Transcriptomics Market Share by Country (2020-2031)
Figure 42. Mexico RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa RNA Analysis Transcriptomics Market Share by Country (2020-2031)
Figure 46. Turkey RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Thermo Fisher Scientific Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 50. Bio-Rad Laboratories Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 51. Merck KGaA Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 52. Agilent Technologies Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 53. Illumina Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 54. QIAGEN N.V. Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 55. F. Hoffmann-La Roche Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 56. Danaher Corporation Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 57. Fluidigm Corporation Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 58. Eurofins Scientific Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 59. Sequentia Biotech Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 60. Acobiom Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 61. GenXPro Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 62. CD Genomics Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 63. Promega Corporation Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 64. Lexogen Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 65. Cenix BioScience Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Table 1. Global RNA Analysis Transcriptomics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Microarrays
Table 3. Key Players of Sequencing
Table 4. Key Players of Polymerase Chain Reaction (PCR)
Table 5. Key Players of RNA Interference
Table 6. Global RNA Analysis Transcriptomics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global RNA Analysis Transcriptomics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global RNA Analysis Transcriptomics Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global RNA Analysis Transcriptomics Market Share by Region (2020-2025)
Table 10. Global RNA Analysis Transcriptomics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global RNA Analysis Transcriptomics Market Share by Region (2026-2031)
Table 12. RNA Analysis Transcriptomics Market Trends
Table 13. RNA Analysis Transcriptomics Market Drivers
Table 14. RNA Analysis Transcriptomics Market Challenges
Table 15. RNA Analysis Transcriptomics Market Restraints
Table 16. Global RNA Analysis Transcriptomics Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global RNA Analysis Transcriptomics Market Share by Players (2020-2025)
Table 18. Global Top RNA Analysis Transcriptomics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Analysis Transcriptomics as of 2024)
Table 19. Ranking of Global Top RNA Analysis Transcriptomics Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by RNA Analysis Transcriptomics Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of RNA Analysis Transcriptomics, Headquarters and Area Served
Table 22. Global Key Players of RNA Analysis Transcriptomics, Product and Application
Table 23. Global Key Players of RNA Analysis Transcriptomics, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global RNA Analysis Transcriptomics Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global RNA Analysis Transcriptomics Revenue Market Share by Type (2020-2025)
Table 27. Global RNA Analysis Transcriptomics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global RNA Analysis Transcriptomics Revenue Market Share by Type (2026-2031)
Table 29. Global RNA Analysis Transcriptomics Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global RNA Analysis Transcriptomics Revenue Market Share by Application (2020-2025)
Table 31. Global RNA Analysis Transcriptomics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global RNA Analysis Transcriptomics Revenue Market Share by Application (2026-2031)
Table 33. North America RNA Analysis Transcriptomics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America RNA Analysis Transcriptomics Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America RNA Analysis Transcriptomics Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe RNA Analysis Transcriptomics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe RNA Analysis Transcriptomics Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe RNA Analysis Transcriptomics Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific RNA Analysis Transcriptomics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific RNA Analysis Transcriptomics Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific RNA Analysis Transcriptomics Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America RNA Analysis Transcriptomics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America RNA Analysis Transcriptomics Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America RNA Analysis Transcriptomics Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa RNA Analysis Transcriptomics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa RNA Analysis Transcriptomics Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa RNA Analysis Transcriptomics Market Size by Country (2026-2031) & (US$ Million)
Table 48. Thermo Fisher Scientific Company Details
Table 49. Thermo Fisher Scientific Business Overview
Table 50. Thermo Fisher Scientific RNA Analysis Transcriptomics Product
Table 51. Thermo Fisher Scientific Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 52. Thermo Fisher Scientific Recent Development
Table 53. Bio-Rad Laboratories Company Details
Table 54. Bio-Rad Laboratories Business Overview
Table 55. Bio-Rad Laboratories RNA Analysis Transcriptomics Product
Table 56. Bio-Rad Laboratories Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 57. Bio-Rad Laboratories Recent Development
Table 58. Merck KGaA Company Details
Table 59. Merck KGaA Business Overview
Table 60. Merck KGaA RNA Analysis Transcriptomics Product
Table 61. Merck KGaA Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 62. Merck KGaA Recent Development
Table 63. Agilent Technologies Company Details
Table 64. Agilent Technologies Business Overview
Table 65. Agilent Technologies RNA Analysis Transcriptomics Product
Table 66. Agilent Technologies Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 67. Agilent Technologies Recent Development
Table 68. Illumina Company Details
Table 69. Illumina Business Overview
Table 70. Illumina RNA Analysis Transcriptomics Product
Table 71. Illumina Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 72. Illumina Recent Development
Table 73. QIAGEN N.V. Company Details
Table 74. QIAGEN N.V. Business Overview
Table 75. QIAGEN N.V. RNA Analysis Transcriptomics Product
Table 76. QIAGEN N.V. Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 77. QIAGEN N.V. Recent Development
Table 78. F. Hoffmann-La Roche Company Details
Table 79. F. Hoffmann-La Roche Business Overview
Table 80. F. Hoffmann-La Roche RNA Analysis Transcriptomics Product
Table 81. F. Hoffmann-La Roche Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 82. F. Hoffmann-La Roche Recent Development
Table 83. Danaher Corporation Company Details
Table 84. Danaher Corporation Business Overview
Table 85. Danaher Corporation RNA Analysis Transcriptomics Product
Table 86. Danaher Corporation Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 87. Danaher Corporation Recent Development
Table 88. Fluidigm Corporation Company Details
Table 89. Fluidigm Corporation Business Overview
Table 90. Fluidigm Corporation RNA Analysis Transcriptomics Product
Table 91. Fluidigm Corporation Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 92. Fluidigm Corporation Recent Development
Table 93. Eurofins Scientific Company Details
Table 94. Eurofins Scientific Business Overview
Table 95. Eurofins Scientific RNA Analysis Transcriptomics Product
Table 96. Eurofins Scientific Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 97. Eurofins Scientific Recent Development
Table 98. Sequentia Biotech Company Details
Table 99. Sequentia Biotech Business Overview
Table 100. Sequentia Biotech RNA Analysis Transcriptomics Product
Table 101. Sequentia Biotech Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 102. Sequentia Biotech Recent Development
Table 103. Acobiom Company Details
Table 104. Acobiom Business Overview
Table 105. Acobiom RNA Analysis Transcriptomics Product
Table 106. Acobiom Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 107. Acobiom Recent Development
Table 108. GenXPro Company Details
Table 109. GenXPro Business Overview
Table 110. GenXPro RNA Analysis Transcriptomics Product
Table 111. GenXPro Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 112. GenXPro Recent Development
Table 113. CD Genomics Company Details
Table 114. CD Genomics Business Overview
Table 115. CD Genomics RNA Analysis Transcriptomics Product
Table 116. CD Genomics Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 117. CD Genomics Recent Development
Table 118. Promega Corporation Company Details
Table 119. Promega Corporation Business Overview
Table 120. Promega Corporation RNA Analysis Transcriptomics Product
Table 121. Promega Corporation Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 122. Promega Corporation Recent Development
Table 123. Lexogen Company Details
Table 124. Lexogen Business Overview
Table 125. Lexogen RNA Analysis Transcriptomics Product
Table 126. Lexogen Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 127. Lexogen Recent Development
Table 128. Cenix BioScience Company Details
Table 129. Cenix BioScience Business Overview
Table 130. Cenix BioScience RNA Analysis Transcriptomics Product
Table 131. Cenix BioScience Revenue in RNA Analysis Transcriptomics Business (2020-2025) & (US$ Million)
Table 132. Cenix BioScience Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. RNA Analysis Transcriptomics Picture
Figure 2. Global RNA Analysis Transcriptomics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global RNA Analysis Transcriptomics Market Share by Type: 2024 VS 2031
Figure 4. Microarrays Features
Figure 5. Sequencing Features
Figure 6. Polymerase Chain Reaction (PCR) Features
Figure 7. RNA Interference Features
Figure 8. Global RNA Analysis Transcriptomics Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global RNA Analysis Transcriptomics Market Share by Application: 2024 VS 2031
Figure 10. Academic & Research Institutes Case Studies
Figure 11. Pharmaceutical & Biotechnology Companies Case Studies
Figure 12. Hospitals Case Studies
Figure 13. RNA Analysis Transcriptomics Report Years Considered
Figure 14. Global RNA Analysis Transcriptomics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global RNA Analysis Transcriptomics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global RNA Analysis Transcriptomics Market Share by Region: 2024 VS 2031
Figure 17. Global RNA Analysis Transcriptomics Market Share by Players in 2024
Figure 18. Global Top RNA Analysis Transcriptomics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Analysis Transcriptomics as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by RNA Analysis Transcriptomics Revenue in 2024
Figure 20. North America RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America RNA Analysis Transcriptomics Market Share by Country (2020-2031)
Figure 22. United States RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe RNA Analysis Transcriptomics Market Share by Country (2020-2031)
Figure 26. Germany RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific RNA Analysis Transcriptomics Market Share by Region (2020-2031)
Figure 34. China RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America RNA Analysis Transcriptomics Market Share by Country (2020-2031)
Figure 42. Mexico RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa RNA Analysis Transcriptomics Market Share by Country (2020-2031)
Figure 46. Turkey RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE RNA Analysis Transcriptomics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Thermo Fisher Scientific Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 50. Bio-Rad Laboratories Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 51. Merck KGaA Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 52. Agilent Technologies Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 53. Illumina Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 54. QIAGEN N.V. Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 55. F. Hoffmann-La Roche Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 56. Danaher Corporation Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 57. Fluidigm Corporation Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 58. Eurofins Scientific Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 59. Sequentia Biotech Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 60. Acobiom Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 61. GenXPro Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 62. CD Genomics Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 63. Promega Corporation Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 64. Lexogen Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 65. Cenix BioScience Revenue Growth Rate in RNA Analysis Transcriptomics Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232